Supreme Court Ruling Could Impact Aredia Case

Law360, New York (March 5, 2008, 12:00 AM EST) -- The parties in the multidistrict product liability litigation involving bone cancer medications Aredia and Zometa have been given the opportunity to weigh in on whether they feel a recent U.S. Supreme Court decision should affect the outcome of the defendants’ pending motion for summary judgment.

On Tuesday, U.S. District Judge Todd Campbell gave both sides three weeks to lay out their arguments for how, if at all, the Supreme Court’s decision in Warner-Lambert Co. vs. Kent alters Novartis Pharmaceuticals’ bid to toss several plaintiffs’ claims that...
To view the full article, register now.